Eisai
4523.T
#2260
Rank
HK$64.99 B
Marketcap
HK$230.38
Share price
-0.78%
Change (1 day)
10.75%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: HK$4.08 Billion

According to Eisai's latest financial reports the company's current earnings are HK$5.06 Billion. In 2023 the company made an earning of HK$4.08 Billion, an increase over its 2022 earnings that were of -HK$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023HK$4.08 B-2404.04%
2022-HK$0.18 Billion-103.6%
2021HK$4.93 B-39.81%
2020HK$8.19 B7.44%
2019HK$7.62 B17.22%
2018HK$6.50 B86.16%
2017HK$3.49 B-23.52%
2016HK$4.57 B26.97%
2015HK$3.60 B22.3%
2014HK$2.94 B-46.07%
2013HK$5.45 B-21.85%
2012HK$6.98 B-20.59%
2011HK$8.79 B-8.91%
2010HK$9.65 B19.21%
2009HK$8.10 B